ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI (Regulate)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01848106
Recruitment Status : Terminated (Clinical Hold)
First Posted : May 7, 2013
Last Update Posted : October 23, 2014
Sponsor:
Collaborators:
The Cleveland Clinic
Duke Clinical Research Institute
Canadian VIGOUR Centre
Icahn School of Medicine at Mount Sinai
Parexel
Information provided by (Responsible Party):
Regado Biosciences, Inc.